STOCK TITAN

IntriCon to Announce 2020 Second-Quarter Results on Monday, August 10, 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

IntriCon Corporation (NASDAQ: IIN) announced the release of its Q2 2020 financial results on August 10, 2020, after market close. A conference call will follow at 4:00 p.m. CT/5:00 p.m. ET, accessible via phone at 866-795-7248 (domestic) or 470-495-9160 (international) with conference ID: 3544449. The event will also be available as a live and archived webcast. IntriCon specializes in designing and manufacturing miniature medical devices, addressing the growing need for compact, intelligent devices.

Positive
  • Scheduled release of Q2 2020 results could provide insights into IntriCon's financial health.
  • Conference call allows direct interaction with management, enhancing investor engagement.
Negative
  • None.

ARDEN HILLS, Minn., July 27, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 second-quarter results on Monday, August 10, 2020, at market close.

Following the release, IntriCon’s management team will host a conference call on the same day, beginning at 4:00 p.m. CT/5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing 866-795-7248 for domestic callers or 470-495-9160 for international callers, using conference ID: 3544449. A live and archived webcast will be available on the “Investors” sections of the company’s website at: www.IntriCon.com.

About IntriCon Corporation
Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature interventional, implantable and body-worn medical devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better-connected devices. IntriCon has facilities in the United States, Asia, the United Kingdom and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market. For more information about IntriCon, visit www.intricon.com.

Investor Relations Contact:
Leigh Salvo
(415) 937-5404
InvestorRelations@intricon.com


FAQ

When will IntriCon Corporation release its Q2 2020 results?

IntriCon Corporation will release its Q2 2020 results on August 10, 2020.

What time is the IntriCon Q2 2020 conference call?

The conference call will be held at 4:00 p.m. CT/5:00 p.m. ET on August 10, 2020.

How can I participate in IntriCon's conference call?

To participate in the conference call, dial 866-795-7248 for domestic or 470-495-9160 for international calls, using conference ID: 3544449.

Where can I find the webcast for IntriCon's conference call?

The webcast will be available on the Investors section of IntriCon's website.

What does IntriCon Corporation specialize in?

IntriCon specializes in designing and manufacturing miniature interventional, implantable, and body-worn medical devices.

IIN

NASDAQ:IIN

IIN Rankings

IIN Latest News

IIN Stock Data

225.49M
7.91M
8.46%
63.11%
1.4%
Medical Instruments & Supplies
Healthcare
Link
United States
Arden Hills